Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials
about
Non-acute percutaneous coronary intervention versus medical therapy in patients with ischaemic heart diseaseTreatment for stable coronary artery disease: a network meta-analysis of cost-effectiveness studiesManagement standards for stable coronary artery disease in India.[National disease management guidelines (NVL) for chronic CAD : What is new, what is particularly important?].Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathyFractional flow reserve-guided percutaneous coronary intervention is not a valid concept.Improvement of Subjective Well-Being by Ranolazine in Patients with Chronic Angina and Known Myocardial Ischemia (IMWELL Study)Variation in patients' perceptions of elective percutaneous coronary intervention in stable coronary artery disease: cross sectional studyOutcomes after first percutaneous coronary intervention for acute myocardial infarction according to patient funding source.Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health StudyWho is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center.Risk of Stroke in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention versus Optimal Medical Therapy: Systematic Review and Meta-Analysis of Randomized Controlled Trials.Impact of multivessel revascularization on health status outcomes in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions.Fractional flow reserve as a surrogate for inducible myocardial ischaemia.Drug-eluting versus bare-metal coronary stents: where are we now?Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention.Challenges with Evidence-Based Management of Stable Ischemic Heart Disease.Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Stable Angina in Advanced CKD: A Decision Analysis.Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study.Comparing Mobile Health Strategies to Improve Medication Adherence for Veterans With Coronary Heart Disease (Mobile4Meds): Protocol for a Mixed-Methods Study.Comprehensive assessment of coronary fractional flow reserve.Choosing between percutaneous coronary intervention and coronary artery bypass graft surgery for nondiabetic patients with multivessel disease.Revascularization for silent ischemia?: another piece of the puzzle.Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model.Reduced Gja5 expression in arterial endothelial cells impairs arteriogenesis during acute ischemic cardiovascular disease.Efficacy of noninvasive cardiac imaging tests in diagnosis and management of stable coronary artery disease.Functional Information in Coronary Artery Disease: The Case of Computed Tomography Myocardial Perfusion.Letter: the treatment of coronary artery disease in cirrhotics needs more thinking.Comparison of mid- to long-term clinical outcomes between anatomical testing and usual care in patients with suspected coronary artery disease: A meta-analysis of randomized trials.Too much coronary angioplasty in the USA?: less may be better - the conflicting roles of inexactness of medicine as a science, asymmetric information, technologic imperative, unnecessary care and ethicomedicinomics in US healthcare.[Recommendations of the ESC guidelines regarding cardiovascular imaging].Propylthiouracil-coated biodegradable polymer inhibited neointimal formation and enhanced re-endothelialization after vascular injury.Current Practices of Percutaneous Coronary Intervention in Korea between 2011 and 2015.Implementation of a cardiac PET stress program: comparison of outcomes to the preceding SPECT era.Percutaneous coronary intervention versus optimal medical therapy for patients with chronic total occlusion: a meta-analysis and systematic review.Patent foramen ovale closure or medical therapy for secondary prevention of cryptogenic stroke: An update meta-analysis of randomized controlled trials
P2860
Q24186673-32138B47-43F1-4E28-803A-4F37D2F2D74AQ28539350-B44A8BF9-A17E-4580-BB11-01CE5E78D5ADQ30239853-9802926F-D7E5-419D-BF96-910E9D0B9C45Q30313892-7F58A2D8-685E-4821-8852-ABAA600F0DD1Q30316766-1FB63467-EFB3-439F-BF60-CC9DAB56AD18Q33647497-68D4F994-E189-4076-93ED-294EF24F1922Q33699147-0DB53A97-BF76-4364-96B6-0D3599E8B09CQ33734021-04DD953E-D8EE-4370-9DCD-B9049ACB1F7DQ34148941-638A94C3-068C-49EF-B573-3544717ABF26Q34668475-A650AA99-B013-4848-83A6-D573EA192814Q35379591-44044CA6-7E3A-4344-B5F0-8B2453785268Q36061898-6B1B57C8-3B6E-46C5-A4AE-345481BCC177Q36071090-238D6BCE-3E54-4AB5-93AC-507F44CB2D8CQ36263380-EE3551F7-FBF8-4666-B8EA-E6F01A8EFA04Q36645771-983F7649-751B-4274-9370-B3DD05F2F233Q38113445-75794869-99FE-430F-8FE9-6067B8C7CC90Q38162864-97F89EE5-716D-4C5C-A551-54931044DAEBQ38652030-BF49635B-53B6-4DBC-806D-5913F787F087Q38986970-11629B51-AD34-4CC5-B0B8-FF51DE60C2A9Q39129336-AC821288-E404-4F64-B8D9-D76DCB3F0DFAQ39373204-F2852A0B-51F3-4C66-A9BD-F4E3561B7C06Q40085577-3A733094-7BEB-497C-9E88-CE8B85DF40B3Q40117787-E3ACB742-76CC-4CBC-BBFB-C307EDED13B7Q41253945-B26E2585-6394-434C-B16D-DC577C91ED93Q42344251-3928F5C7-67FB-4050-AD08-9E63EF12D200Q43089674-99B944E0-775E-41E5-A05C-EFB491C3E29EQ46806315-371A9CA2-8FFB-400A-9487-EF24CA69043DQ47094282-51192460-37C3-47AF-9EC7-DE6F3753499BQ47155873-4AB670EA-F91B-4C72-89EF-DE67EFA6520EQ47876408-6251320A-AFF1-4ABB-9C1B-AD69FFBDDC19Q48245595-BBC9553F-0CDB-4F6C-8B72-A0656B780F80Q48339157-704946F0-7ECD-4119-9C90-24F9B9F61A6AQ50635562-6AC84A88-D49C-4884-94C6-C5A6E3E7AFBFQ52981853-639D1601-A91C-4978-A686-DD96AFFE2A51Q55040250-1BFDB9C2-041B-4F38-BE98-DDE9B24D3E2FQ55360115-042C9C10-73F7-433B-B858-8122AC63FEC3Q55383701-9714BA43-D677-4648-B0DA-4B478F4561A2Q55667508-8CCB2D0A-F8F0-4D73-8F76-A8D1FE2E6EF0Q58706609-980DCF4E-2152-406C-8241-DA239EC1497F
P2860
Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Percutaneous coronary interven ...... of randomized clinical trials
@ast
Percutaneous coronary interven ...... of randomized clinical trials
@en
Percutaneous coronary interven ...... of randomized clinical trials
@nl
type
label
Percutaneous coronary interven ...... of randomized clinical trials
@ast
Percutaneous coronary interven ...... of randomized clinical trials
@en
Percutaneous coronary interven ...... of randomized clinical trials
@nl
prefLabel
Percutaneous coronary interven ...... of randomized clinical trials
@ast
Percutaneous coronary interven ...... of randomized clinical trials
@en
Percutaneous coronary interven ...... of randomized clinical trials
@nl
P2093
P31
P3181
P1476
Percutaneous coronary interven ...... of randomized clinical trials
@en
P2093
Frederick Korley
Newry Chandra
Pushkar Kanade
Ravindra Gopaul
Richard E Shaw
Seema Pursnani
Sripal Bangalore
P304
P3181
P356
10.1161/CIRCINTERVENTIONS.112.970954
P407
P577
2012-08-01T00:00:00Z